CV Sciences, Inc.
CVSI · OTCMCIK 1510964fmd_0K44K49119X3ZFEKR0MWGSXNZJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Jun 30, 2026, 62 periods
Latest annual · FY2025
Millions- Total revenues
- 14
- Gross profit
- 7
- Operating income
- (0)
- Net income
- (1)
- Free cash flow
- (1)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 3
- Gross profit
- 1
- Operating income
- (0)
- Net income
- (1)
- Free cash flow
- 0
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -5.2%
- Revenue, 5 yearsFY2020 to FY2025
- -10.8%
- Net income, 5 yearsFY2020 to FY2025
- n/m
CV Sciences, Inc. (CVSI) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $13.8 million | $15.7 million | -12.2% | 10-K 2026-03-26 · proof |
| Gross profit | $6.8 million | $7.2 million | -5.8% | 10-K 2026-03-26 · proof |
| Operating income | -$470,000 | -$2.2 million | 10-K 2026-03-26 · proof | |
| Net income | -$958,000 | -$2.4 million | 10-K 2026-03-26 · proof | |
| Cash from operating activities | -$407,000 | -$861,000 | 10-K 2026-03-26 · proof | |
| Free cash flow | -$516,000 | -$879,000 | 10-K 2026-03-26 · proof | |
| Total assets | $7 million | $7.9 million | -12.2% | 10-K 2026-03-26 · proof |
| Total liabilities | $5.5 million | $6.1 million | -10.4% | 10-K 2026-03-26 · proof |
| Cash and cash equivalents | $278,000 | $454,000 | -38.8% | 10-K 2026-03-26 · proof |
| Total debt | $1.6 million | $677,000 | +143.6% | 10-K 2026-03-26 · proof |
- What was CV Sciences, Inc. (CVSI)'s revenue in fiscal 2025?
- CV Sciences, Inc. (CVSI) reported revenue of $13.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $15.7 million the year before (-12.2%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was CV Sciences, Inc. (CVSI)'s gross profit in fiscal 2025?
- CV Sciences, Inc. (CVSI) reported gross profit of $6.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $7.2 million the year before (-5.8%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was CV Sciences, Inc. (CVSI)'s operating income in fiscal 2025?
- CV Sciences, Inc. (CVSI) reported operating income of -$470,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was CV Sciences, Inc. (CVSI)'s net income in fiscal 2025?
- CV Sciences, Inc. (CVSI) reported net income of -$958,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$2.4 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was CV Sciences, Inc. (CVSI)'s cash from operating activities in fiscal 2025?
- CV Sciences, Inc. (CVSI) reported cash from operating activities of -$407,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$861,000 the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was CV Sciences, Inc. (CVSI)'s free cash flow in fiscal 2025?
- CV Sciences, Inc. (CVSI) reported free cash flow of -$516,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$879,000 the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are CV Sciences, Inc. (CVSI)'s total assets?
- As of Dec 31, 2025, CV Sciences, Inc. (CVSI) reported total assets of $7 million, against $7.9 million a year earlier (-12.2%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are CV Sciences, Inc. (CVSI)'s total liabilities?
- As of Dec 31, 2025, CV Sciences, Inc. (CVSI) reported total liabilities of $5.5 million, against $6.1 million a year earlier (-10.4%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are CV Sciences, Inc. (CVSI)'s cash and cash equivalents?
- As of Dec 31, 2025, CV Sciences, Inc. (CVSI) reported cash and cash equivalents of $278,000, against $454,000 a year earlier (-38.8%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What is CV Sciences, Inc. (CVSI)'s total debt?
- As of Dec 31, 2025, CV Sciences, Inc. (CVSI) reported total debt of $1.6 million, against $677,000 a year earlier (+143.6%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CVSI&period_type=annual&limit=5"Information only, not investment advice.